sPD-L1 levels at baseline were positively associated with clinical outcome in NSCLC patients after surgery [47] and hepatocellular carcinoma patients following hepatic resection or liver transplantation [234]. The gene discussed is SPDL1; the disease is non-small cell lung carcinoma.